Search Results

Propensity Score–Matched Analysis of Early Clinical Outcomes From the CLOUT and ATTRACT Studies Presented

November 2, 2022—A propensity score–matched analysis found that patients in the CLOUT registry of mechanical thrombectomy with the ClotTriever (Inari Medical, Inc.) showed better thrombus extraction and improvement in 30-day Villalta scores than patients in the ATTRACT trial of interventional treatment for deep vein thrombosis (DVT).

Pain and QoL Data Presented for Gore’s Viabahn Fortegra Venous Stent

April 22, 2026—Gore & Associates announced new 12-month findings from the global GORE VIABAHN FORTEGRA Venous Stent IVC trial, which evaluated treatment of patients with symptomatic deep venous iliocaval obstruction.

Inari Medical Begins DEFIANCE Randomized Clinical Trial of ClotTriever System in DVT

January 12, 2023—Inari Medical, Inc. announced that the first patient has been enrolled in the DEFIANCE prospective randomized controlled trial (RCT) comparing the clinical outcomes of patients with iliofemoral deep vein thrombosis (DVT) treated with the company’s ClotTriever system versus anticoagulation only.

Inari Medical’s ClotTriever System Will Be Evaluated to Treat DVT in DEFIANCE Trial

August 30, 2022—Inari Medical, Inc. announced the planned enrollment of the DEFIANCE randomized controlled trial (RCT).

Subanalysis Results Presented From Real-World CLOUT Registry of Inari Medical’s ClotTriever

January 25, 2021—Inari Medical, Inc. announced interim results of the first 64 chronic deep vein thrombosis (DVT) patients enrolled in CLOUT, the company’s ClotTriever Outcomes Registry.

Inari Medical Launches RevCore and Triever16 Curve Devices to Treat Venous Stent Thrombosis and VTE

June 7, 2023—Inari Medical, Inc. announced the launch of the RevCore thrombectomy catheter and the Triever16 Curve catheter.

Imperative Care Launches CLEAR-IT Peripheral Thromboembolism Study

March 25, 2025—Imperative Care, Inc. announced the enrollment of the first patient in the prospective observational CLEAR-IT clinical study evaluating the performance of the company’s Symphony and Prodigy systems, which are aspiration-based technologies used in endovascular thrombectomy procedures across the peripheral and pulmonary vasculature.

Inari’s ClotTriever Studied in Real-World CLOUT Registry of DVT Patients

June 7, 2021—Inari Medical, Inc. announced interim results of the first 250 deep vein thrombosis (DVT) patients enrolled in the prospective CLOUT registry.